- Conditions
- Advanced Non-Small Cell Lung Cancer, EGFR Mutation, HER2 Mutation
- Locations
-
- Banner MD Anderson Cancer Center at Banner Gateway Medical Center Gilbert, Arizona, United States
- City of Hope - Duarte Cancer Center Duarte, California, United States
- Emory Winship Cancer Institute Atlanta, Georgia, United States
- The Center for Cancer and Blood Disorders Bethesda, Maryland, United States
Clinical trial condition
HER2 Mutation
Explore clinical trials studying HER2 Mutation. Study availability and eligibility vary by location and protocol.
8 public trials
2 recruiting studies
HER2 Mutation trial results
- Conditions
- Adnexal Diseases, Advanced Solid Tumors, Biliary Tract Diseases, +53 more
- Locations
-
- UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
- City of Hope - Duarte Cancer Center Duarte, California, United States
- Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus Fort Myers, Florida, United States
- Dana-Farber Cancer Institute - Oncology Department Boston, Massachusetts, United States
Not yet recruiting
A Phase II Study of Zongertinib Plus Fulvestrant in Participants With HR-positive/HER2-negative Advanced Breast Cancer Harboring HER2 Mutations.
NCT07619066
- Conditions
- Advanced Breast Cancer, HER2 Mutation, Hormone Receptor Positive / HER2-negative Breast Cancer
- Locations
-
Not specified
NCT06378658
- Conditions
- Advanced Non-Small Cell Lung Cancer, EGFR Mutation, HER2 Mutation, +1 more
- Locations
-
- Parexel Baltimore - Early Phase Clinical Unit Baltimore, Maryland, United States
NCT06329895
- Conditions
- Advanced Non-Small Cell Lung Cancer, EGFR Mutation, HER2 Mutation, +1 more
- Locations
-
- PAREXEL International Early Phase Clinical Unit (London) Harrow, United Kingdom
NCT06360211
- Conditions
- Advanced Non-Small Cell Lung Cancer, EGFR Mutation, HER2 Mutation, +1 more
- Locations
-
- Parexel Baltimore - Early Phase Clinical Unit Baltimore, Maryland, United States
Completed
A Study to Learn How BAY2927088 is Taken up and Handled by the Body in Healthy Male Participants
NCT06221475
- Conditions
- Advanced Non-Small Cell Lung Cancer, EGFR Mutation, HER2 Mutation, +1 more
- Locations
-
- ICON plc Groningen, Netherlands
NCT06348888
- Conditions
- Advanced Non-Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +11 more
- Locations
-
- Parexel Baltimore - Early Phase Clinical Unit Baltimore, Maryland, United States